Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GPR171 Antikörper (2nd Extracellular Loop)

Der Kaninchen Polyklonal anti-GPR171 Antikörper wird verwendet zum Nachweis von GPR171 in Proben von Maus. Er wurde validiert für WB, FACS und LCI.
Produktnummer ABIN7886444
1.184,62 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für GPR171 Antikörper (2nd Extracellular Loop) (ABIN7886444)

Target

Alle GPR171 Antikörper anzeigen
GPR171 (G Protein-Coupled Receptor 171 (GPR171))

Reaktivität

  • 36
  • 8
  • 7
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
Maus

Wirt

  • 37
Kaninchen

Klonalität

  • 37
Polyklonal

Konjugat

  • 23
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser GPR171 Antikörper ist unkonjugiert

Applikation

  • 20
  • 13
  • 9
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Bindungsspezifität

    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    2nd Extracellular Loop, AA 155-169

    Verwendungszweck

    A Rabbit Polyclonal Antibody to GPR171

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Mouse,15 amino acid residues identical, rat - 13,human - 14

    Produktmerkmale

    Anti-GPR171 (extracellular) Antibody (ABIN7043150, ABIN7044447 and ABIN7044448) is a highly specific antibody directed against an epitope of the mouse protein. The antibody can be used in western blot and live cell flow cytometry. It has been designed to recognize GPR171 from human, rat, and mouse samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Peptide (C)KDIKEKSNVG(S)MEFK, corresponding to amino acid residues 155 - 169 of mouse GPR171.

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200

    FC: 5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: The optimal concentration should be determined by the user

    IP: The optimal concentration should be determined by the user

    Kommentare

    Negative Control: (ABIN7235380)

    Blocking Peptide: (ABIN7235380)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    GPR171 (G Protein-Coupled Receptor 171 (GPR171))

    Andere Bezeichnung

    GPR171

    Hintergrund

    Synonyms: G-Protein Coupled Receptor 171, Platelet Activating Receptor Homolog, G-protein coupled receptor H963

    Description: G protein-coupled receptor 171 (GPR171) is an orphan G-protein coupled receptor (GPCR) activated by BigLEN, one of the most abundant neuropeptides in the brain that is derived from ProSAAS1. GPR171 contains seven transmembrane domains, an extracellular N-terminus and an intracellular C-terminal tail. Its detailed structure and ligand binding domain structure was predicted by homology modeling based on its similarity to P2Y12 receptor2,3.BigLEN-GPR171 neuropeptide-receptor system is expressed in the brain, at the basolateral amygdala (BLA) and the periaqueductal gray brain area4-6.This system plays an important role in regulating feeding-related behaviors, food intake and body weight regulation. It is also involved in anxiety behavior and various psychiatric disorders4,5.Furthermore, BigLEN-GPR171 are expressed in GABAergic neurons within the periaqueductal gray, a key brain area involved in pain modulation and opioid functions6.GPR171 is a potential target for drug development in obesity and weight problems, anxiety, various psychiatric disorders and pain.

    Gen-ID

    229323

    NCBI Accession

    NM_013308

    UniProt

    Q8BG55
Sie sind hier:
Chat with us!